Voyageur Pharmaceuticals AI Stock Analysis
Voyageur Pharmaceuticals (VYYRF) AI Stock Analysis
Voyageur Pharmaceuticals
(Other OTC:VYYRF)
No summary available
Voyageur Pharmaceuticals (VYYRF) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $20.25M
- Dividend Yield
- ―
- Average Volume (3M)
- 49.62K
- Price to Earnings (P/E)
- -6.8
- Beta (1Y)
- -25.47
- Revenue Growth
- 357.24%
- EPS Growth
- 14.08%
- Country
- US
- Employees
- 49
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Voyageur Pharmaceuticals Business Overview & Revenue Model
Company Description
Voyageur Pharmaceuticals Ltd. specializes in the creation of mineral-based active pharmaceutical ingredients (APIs). The company aims to produce radiocontrast agents utilizing barium and iodine, along with pharmaceutical products derived from bromine...
Voyageur Pharmaceuticals Peers Comparison
Overall Rating
TSE:AVCN58Neutral
TSE:LABS57Neutral
TSE:ROMJ48Neutral
TSE:INNO41Neutral
TSE:PCLO39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 58Neutral | CAD 12.09M | -3.98 | -65.40% | ― | -3.32% | -34.15% | |
| 57Neutral | CAD 27.77M | -9.23 | -7.66% | ― | -9.31% | 66.84% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 48Neutral | CAD 23.99M | -5.33 | -10.97% | ― | 16.91% | -244.25% | |
| 41Neutral | CAD 8.28M | -6.18 | -19.37% | ― | -19.20% | 42.54% | |
| 39Underperform | CAD 8.41M | -2.41 | 28.59% | ― | 0.90% | 57.73% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| VYYRF | Voyageur Pharmaceuticals Ltd. | 0.09 | -0.01 | -11.00% | |
| TSE:LABS | Medipharm Labs (Otc) | 0.06 | -0.01 | -7.69% | |
| TSE:PCLO | Pharmacielo | 0.04 | 0.00 | 0.00% | |
| TSE:ROMJ | Rubicon Organics | 0.35 | -0.10 | -21.11% | |
| TSE:AVCN | Avicanna Inc | 0.09 | -0.15 | -63.33% | |
| TSE:INNO | Innocan Pharma Corporation | 1.84 | -13.55 | -88.04% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
